Phase II Study of Tesetaxel in Metastatic Melanoma
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if tesetaxel can help to control
metastatic melanoma. The safety of this drug will also be studied.